Wednesday, November 4, 2009

Insulet Announces Pricing of Public Offering Oct.26-30-Week 3

Insulet Corporation announced the prices of its public offering of 6,000,000 shares of at $10.25 per share of common stock. Insulet is planning to use this money for general corporate purposes, which may used twards the repayment of certain debts. Insulet has offered the underwriters to purchase up to an additional 900,000 shares of stock to pay for any over-allotments.
Posted by at

3 comments:

  1. AndyNovember 5, 2009 at 10:24 AM

    This comment has been removed by the author.

    ReplyDelete
  2. AndyNovember 5, 2009 at 10:29 AM

    You could have discussed who/what Insulet Corporation is (Medical Device Company). You could have also stated where Insulet Corporation is located. A nice detail that could have been added would have been that J.P. Morgan Securities Inc. is the sole book-running manager of the offer, with Canaccord Adams Inc. and JMP Securites LLC acting as co-managers.

    ReplyDelete
  3. Brandon M.November 5, 2009 at 10:32 AM

    You say that they are going to spend that money on debt. Do you think investing in a company in debt is a good idea?

    ReplyDelete

Subscribe to: Post Comments (Atom)